Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Business Times.
Press releases published on April 23, 2025

PDS Biotech Announces Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
PRINCETON, N.J., April 23, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …

FlexShopper, Inc. Reports 2024 Fourth-Quarter and Year-End Financial Results
Ongoing DTC and B2B growth strategies drove a 19.5% year-over-year increase in annual revenue Operating income for 2024 increased 66% to $22.8 million, and adjusted EBITDA increased 43.1% to $33.3 million, as a result of higher revenue, controlled expenses …

Kiosk Market is expected to generate a revenue of USD 62.2 Billion by 2031, Globally, at 12.74% CAGR: Verified Market Research®
Lewes, Delaware, April 23, 2025 (GLOBE NEWSWIRE) -- The Global Kiosk Market Size is projected to grow at a CAGR of 12.74% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals that the market was valued at …

Mersana Therapeutics Announces Upcoming Emi-Le Oral and Poster Presentations at ASCO 2025 Annual Meeting
CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of …

Allogene Therapeutics to Present Updated ALLO-316 Clinical Results in Kidney Cancer in Oral Presentation and ALPHA3 Trial-in-Progress Poster for Cema-Cel at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today …

Firefly Aerospace Awarded AFRL Contract to Develop Ceramic Matrix Composite Rocket Engine Nozzle Extension
Built with lightweight composite material, nozzle extensions will lower costs, improve performance, and accelerate rocket engine production CEDAR PARK, Texas, April 23, 2025 (GLOBE NEWSWIRE) -- Firefly Aerospace, the leader in end-to-end responsive space …

Riyadh Air Sets High Safety Standards for Pilot Training by Selecting CEFA Aviation’s FAS
COLMAR, FRANCE, April 23, 2025 /EINPresswire.com/ -- Riyadh Air, Saudi Arabia’s premier new flag carrier, has selected CEFA Aviation, a leading provider of flight data animation solutions, to provide its CEFA FAS (Flight Animation System) software to …

DeFi Tax Uncovers Systemic Failures in Crypto Tax Reporting Leaving Millions of U.S. Taxpayers at Risk Ahead of New IRS 1099-DA Regulations
SHERIDAN, Wyo., April 23, 2025 (GLOBE NEWSWIRE) -- A multi-year investigation by crypto tax experts revealed pervasive, critical flaws in the current crypto tax reporting ecosystem in a newly published report, warning of dire consequences for traders, …

Morris State Bancshares Announces Quarterly Earnings and Declares Second Quarter Dividend
DUBLIN, Ga., April 23, 2025 (GLOBE NEWSWIRE) -- Morris State Bancshares, Inc. (OTCQX: MBLU) (the “Company”), the parent of Morris Bank, today announced net income of $4.9 million for the quarter ending March 31, 2025, representing an increase of $22 …

Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting
FDA recently granted Breakthrough Device Designation to AVIM therapy for use in patients with uncontrolled hypertension at increased cardiovascular risk HRS Satellite Symposium will feature leading experts in electrophysiology, hypertension management and …

NEVADA CANYON ANNOUNCES SIGNIFICANT RESULTS FROM INITIAL EXPLORATION PROGRAM ON THE AGAI PAH PROPERTY
Reno, Nevada, April 23, 2025 (GLOBE NEWSWIRE) -- Canyon Gold Corp. (OTCQX Markets: NGLD) (The “Company” or “Nevada Canyon”) is pleased to announce results from the initial Phase I exploration program on one of the Company’s Accelerator properties, the Agai …

Oragenics, Inc. to Participate at the 15th Annual Traumatic Brain Injury Conference
SARASOTA, Fla., April 23, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing novel intranasal therapies for concussion and brain-related conditions, today announced its participation in the 15th Annual …

Lipella Pharmaceuticals Abstract on Oral Lichen Planus Treatment Accepted for Podium Presentation at 2025 AAOM/EAOM International Meeting Conference on “Global Transformation in Oral Medicine”
Joint meeting to be held in Las Vegas, May 14-17 Presentation will be delivered by Dr. Alessandro Villa of Miami Cancer Institute Topline study results demonstrate clinically meaningful improvements in OLP Visible lesion resolution during treatment; return …

Bluejay Therapeutics Announces Upcoming Presentation of Preclinical Data in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at European Association for the Study of the Liver (EASL) Congress 2025
REDWOOD CITY, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious viral and liver diseases, today announced it will present …

NewtekOne, Inc. Announces Peter Downs has been named President of Newtek Bank, N.A.
BOCA RATON, Fla., April 23, 2025 (GLOBE NEWSWIRE) -- Boca Raton, FL, April 23, 2025 - NewtekOne, Inc. (the “Company”) (NASDAQ: NEWT) announced that Peter Downs has been named President of Newtek Bank, N.A. (the “Bank”). In addition, Frank M. DeMaria has …

Enlivex Therapeutics to Showcase Allocetra’s Potential in Osteoarthritis at OARSI 2025 World Congress
Presentations to underscore AllocetraTM’s novel mechanism targeting immune imbalance in joint disease Ness-Ziona, Israel, April 23, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming …

Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites
The Company is now preparing for the enrollment of the first patient to receive Clearmind’s innovative treatment as part of the trial Vancouver, Canada, April 23, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or …

Puma Exploration Launches its 2025 Exploration Program at Williams Brook
RIMOUSKI, Québec, April 23, 2025 (GLOBE NEWSWIRE) -- Puma Exploration Inc. (TSXV: PUMA, OTCQB: PUMXF) (the “Company” or “Puma”) is thrilled to announce the launch of its 2025 exploration programs in Northern New Brunswick. After weeks of compiling data, …

Hanover Bancorp, Inc. Reports First Quarter 2025 Results Highlighted by Accelerated Margin Expansion, Improved Credit Quality Metrics & Successful Core Banking System Conversion
First Quarter Performance Highlights Net Income: Net income for the quarter ended March 31, 2025 totaled $1.5 million or $0.20 per diluted share (including Series A preferred shares). Adjusted (non-GAAP) net income (excluding core system conversion …

Presented by Atticus Publishing: Mastering Time with 'The Box is Time'
‘An Unconventional Approach to Time Management by Dr. Raymond A Costabile’ SAN FRANCISCO, CA, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- Atticus Publishing proudly presents The Box is Time, a revolutionary book by Dr. Raymond A Costabile that …